INS and diabetes mellitus: Additionally, conophylline administration (0.9 mg/kg/day, oral gavage) for 4 weeks improved glucose tolerance, increased pancreatic insulin, reduced islet fibrosis, and increased the number of MafA-positive β-cells in Goto-Kakizaki rats, a non-hypertensive model of diabetes [75].